“…Both diseases have early onset, with AOA4 being the earliest (mean age onset 4.3 vs. 6.9 years for AOA1). Extra-neurologic features are also similar as half of the AOA4 cases have low albumin and high cholesterol, features found consistently in older AOA1 patients (Barbot et al, 2001; Bras et al, 2015; Moreira et al, 2001; Yokoseki et al, 2011). A clinically related syndrome AOA2, is caused by mutations in Senataxin (Anheim et al, 2009; Hammer et al, 2012; Le Ber et al, 2004; Moreira et al, 2004), a helicase, which is associated with DNA damage responses, transcriptional control and possibly a SSBR defect (Bennett and La Spada, 2015; Hamperl and Cimprich, 2014; Richard et al, 2013; Suraweera et al, 2007).…”